Clinical trials: Benign Pancreas Tumor
Pancreatic Malignant Neoplasm Primary
Evaluation of Outcomes From Treatment of Benign or Malignant Gastroesophageal Diseases
This study will be a retrospective chart review of patients who have been diagnosed with benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr.
- Trial name
- NCT04637256
- Where
- United States
- Volunteers
- 500 people
- Sponsor
- Methodist Health System
Benign Breast Disease, Breast Cancer
Prolactin Receptor and Breast Diseases
Prolactin is known to play an important role in breast development and differentiation. Thus proliferative breast diseases are good models to unravel PRl / PRLR function in proliferative processes.
- Trial name
- Prolacsein (NCT00842465)
- Testing
- blood collection for hormonal status analysis, breast Biopsy or surgery, blood collection
- Where
- France
- Volunteers
- 735 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Breast Cancer, Benign Breast Disease
Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda
Breast cancer incidence is increasing in low- and middle-income countries (LMICs) and breast cancer mortality is high in these regions largely due to late stage diagnoses.
- Conditions
- Breast Cancer, Benign Breast Disease, Cervix Cancer
- Trial name
- NCT05364138
- Where
- Rwanda
- Volunteers
- 2,357 people, healthy volunteers welcome
- Sponsor
- Brigham and Women's Hospital
Pancreatic Neuroendocrine Tumors
Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms
To determine the efficacy and safety of robotic, laparoscopic and open surgery for enucleation of benign pancreatic neuroendocrine tumors
- Trial name
- NCT02125929
- Testing
- Robotic surgery, Laparoscopic surgery, Open surgery
- Where
- China
- Volunteers
- 156 people
- Sponsor
- Peking Union Medical College Hospital
Benign Pancreas Tumor, Malignant Pancreatic Neoplasm
Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital.
There is a need for a structured registry to collect real-world data on patient characteristics, surgical strategies, perioperative outcomes, and long-term results.
- Trial name
- PANREG (NCT07443761)
- Where
- Belgium
- Volunteers
- 2,000 people
- Sponsor
- University Hospital, Antwerp
Partial Pancreatectomy Due to Benign Pancreatic Neoplasm
Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug.
Effects of autologous islet transplantation were compared to those of oral anti-diabetic drugs after distal pancreatectomy. The primary interest is a insulin-secretory function after the surgery in two intervention groups.
- Trial name
- NCT01922492
- Testing
- Autologous islet transplantation, Oral anti-diabetic drugs
- Where
- South Korea
- Volunteers
- 28 people
- Sponsor
- Seoul National University Hospital
Pancreas Cancer
DNA Microarray Study of Pancreas Cancer
Pancreas cancer and precancerous cysts can be difficult to diagnose. Sometimes biopsies do not show cancer when cancer is actually present.
- Trial name
- NCT00680420
- Testing
- fine needle aspiration biopsy
- Where
- United States
- Volunteers
- 27 people
- Sponsor
- Oregon Health and Science University
Biliary Tract Neoplasms, Pancreatic Carcinoma
A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up
Chromosomal instability (CIN) refers to ongoing chromosome segregation errors throughout consecutive cell divisions. CIN is a hallmark of human cancer, and it is associated with poor prognosis, metastasis, and therapeutic…
- Conditions
- Biliary Tract Neoplasms, Pancreatic Carcinoma, Gallbladder Cancer, Pancreatic Head Carcinoma
- Trial name
- NCT05237193
- Testing
- The level of CIN
- Where
- China
- Volunteers
- 400 people
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Minimally Invasive Distal Pancreatectomy
Registrar Performances in MIDP
This study aimed to determine whether registrar involvement in minimally invasive distal pancreatectomy (MIDP) was associated with adverse outcomes.
- Trial name
- NCT04429074
- Testing
- Minimally invasive distal pancreatectomy
- Where
- France
- Volunteers
- 71 people
- Sponsor
- University Hospital, Montpellier